FIELD: medicine.
SUBSTANCE: group of inventions relates to the treatment of colon cancer. Presented is a method of treating colon cancer involving administering a pharmaceutically acceptable amount of a PDE1 inhibitor to a subject in need thereof, wherein the PDE1 inhibitor is
or
in free form or in the form of a pharmaceutically acceptable salt. Also disclosed is an embodiment of said method, comprising additionally administering a PD-1 inhibitor, and a method of inhibiting proliferation, migration and/or invasion of cancer or tumour cells in the colon, comprising administering a pharmaceutically acceptable amount of said PDE1 inhibitor to a subject in need thereof suffering from colon cancer.
EFFECT: invention provides effective treatment of colon cancer.
11 cl, 2 dwg, 2 ex
Title |
Year |
Author |
Number |
METHODS OF TREATING CANCER DISEASES AND TUMORS USING PDE1 INHIBITORS |
2019 |
- Wennogle, Lawrence P.
- Hendrick, Joseph
- Davis, Robert
|
RU2811918C2 |
ANTITUMOUR AGENT |
2006 |
- Josinaga Kodzi
- Kavasaki Dajsuke
- Ehmori Jutaka
|
RU2391982C2 |
COMBINED DRUG FOR TREATMENT OF TUMOR DISEASES |
2002 |
- Binderup Lize
- Bramm Ehrik
- Jarno Pernille-Julija Vig
- Khamberg Karin Eksner
|
RU2291710C2 |
ANTICANCER COMPOSITION CONTAINING A RECOMBINANT ADENOVIRUS EXPRESSING A DESTRUCTIVE FACTOR FOR AN EXTRACELLULAR MATRIX |
2017 |
|
RU2742726C2 |
METHOD FOR PREDICTING THERAPEUTIC EFFICACY OF PI3K/AKT/mTOR INHIBITOR ON BASIS OF PHLDA1 OR PIK3C2B EXPRESSION |
2014 |
- Abe Tetsuya
- Itadani Khiraku
|
RU2666921C2 |
USE OF THE PLINABULIN IN COMBINATION WITH THE IMMUNE RESPONSE CONTROL POINT INHIBITORS |
2016 |
- Khuan Lan
- Li Gloriya Tsi-Ji
|
RU2723021C2 |
COMPOSITIONS BASED ON SHP2 INHIBITOR AND METHODS OF CANCER TREATMENT |
2018 |
- Nichols, Robert J.
- Goldsmith, Mark A.
- Schulze, Christopher
- Smith, Jacqueline
- Wildes, David E.
- Kelsey, Stephen
- Singh, Mallika
|
RU2805355C2 |
COMPOSITIONS CONTAINING TUCARESOL OR ANALOGUES THEREOF |
2017 |
- Khuan Lan
- Mokhanlal Ramon
- Llojd Dzhordzh Kennet
|
RU2753543C1 |
COMBINED THERAPY WITH TETRACYCLIC QUINOLONE ANALOGUES FOR CANCER TREATMENT |
2016 |
|
RU2752506C2 |
PREPARATION POTENTIATING RADIATION THERAPY |
2007 |
|
RU2435587C2 |